News | June 09, 2023
Cosette Pharmaceuticals acquires Intrarosa from Endoceutics
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
US formulations revenue increased by 11.6% YoY to Rs. 3,045 crore and Europe formulation revenue stood at Rs. 1,660 crore
India’s efforts are aimed at boosting health at the last mile
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Subscribe To Our Newsletter & Stay Updated
